PE20110394A1 - Virus sincitial respiratorio vivo atenuado - Google Patents
Virus sincitial respiratorio vivo atenuadoInfo
- Publication number
- PE20110394A1 PE20110394A1 PE2011000971A PE2011000971A PE20110394A1 PE 20110394 A1 PE20110394 A1 PE 20110394A1 PE 2011000971 A PE2011000971 A PE 2011000971A PE 2011000971 A PE2011000971 A PE 2011000971A PE 20110394 A1 PE20110394 A1 PE 20110394A1
- Authority
- PE
- Peru
- Prior art keywords
- protein coded
- gen
- gene
- protein
- glutamic acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C07K14/08—RNA viruses
- C07K14/115—Paramyxoviridae, e.g. parainfluenza virus
- C07K14/135—Respiratory syncytial virus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- C12N7/04—Inactivation or attenuation; Producing viral sub-units
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/543—Mucosal route intranasal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/544—Mucosal route to the airways
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
- C12N2760/18522—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
- C12N2760/18534—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
- C12N2760/18561—Methods of inactivation or attenuation
- C12N2760/18564—Methods of inactivation or attenuation by serial passage
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Pulmonology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
Abstract
REFERIDA A UN VIRUS SINCITIAL RESPIRATORIO VIVO ATENUADO (VSR) QUE COMPRENDE UN GENOMA VIRAL QUE CODIFICA PROTEINAS QUE COMPRENDEN UNO O MAS AMINOACIDOS TALES COMO: UN ACIDO GLUTAMICO EN LA POSICION 204 DE LA PROTEINA CODIFICADA POR EL GEN G, UN ACIDO GLUTAMICO EN LA POSICION 205 DE LA PROTEINA CODIFICADA POR EL GEN G, UNA ALANINA EN LA POSICION 211 DE LA PROTEINA CODIFICADA POR EL GEN G, UN ACIDO GLUTAMICO EN LA POSICION 213 DE LA PROTEINA CODIFICADA POR EL GEN G, UNA GLICINA EN LA POSICION 221 DE LA PROTEINA CODIFICADA POR EL GEN G, UN ACIDO GLUTAMICO EN LA POSICION 223 DE LA PROTEINA CODIFICADA POR EL GEN G, UNA GLICINA EN LA POSICION 232 DE LA PROTEINA CODIFICADA POR EL GEN G, UNA LISINA EN LA POSICION 294 DE LA PROTEINA CODIFICADA POR EL GEN F, UNA GLICINA EN LA POSICION 486 DE LA PROTEINA CODIFICADA POR EL GEN F, UNA ALANINA EN LA POSICION 148 DE LA PROTEINA CODIFICADA POR EL GEN L Y UNA FENILALANINA EN LA POSICION 2054 DE LA PROTEINA CODIFICADA POR EL GEN L. TAMBIEN ESTA REFERIDA A UNA MOLECULA DE ACIDO NUCLEICO, UNA CELULA RECOMBINANTE Y A UNA COMPOSICION INMUNOGENICA. DICHOS VIRUS ATENUADOS SON UTILES COMO VACUNAS CONTRA INFECCIONES POR VSR Y/O ENFERMEDADES ASOCIADAS AL MISMO
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US19832708P | 2008-11-05 | 2008-11-05 |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20110394A1 true PE20110394A1 (es) | 2011-06-22 |
Family
ID=41527812
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2011000971A PE20110394A1 (es) | 2008-11-05 | 2009-11-03 | Virus sincitial respiratorio vivo atenuado |
Country Status (19)
Country | Link |
---|---|
US (1) | US9011876B2 (es) |
EP (1) | EP2346990B1 (es) |
JP (2) | JP5016731B2 (es) |
KR (1) | KR20110063863A (es) |
CN (1) | CN102272295A (es) |
AU (1) | AU2009311287C1 (es) |
BR (1) | BRPI0921424A2 (es) |
CA (1) | CA2742086A1 (es) |
CL (1) | CL2011000999A1 (es) |
CO (1) | CO6362047A2 (es) |
EC (1) | ECSP11011033A (es) |
IL (1) | IL212437A0 (es) |
MA (1) | MA32878B1 (es) |
MX (1) | MX2011004719A (es) |
PE (1) | PE20110394A1 (es) |
RU (1) | RU2011122615A (es) |
TN (1) | TN2011000182A1 (es) |
WO (1) | WO2010053883A1 (es) |
ZA (1) | ZA201103259B (es) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2346990B1 (en) * | 2008-11-05 | 2016-01-06 | Merck Sharp & Dohme Corp. | Live, attentuated respiratory syncytial virus |
WO2013026054A2 (en) * | 2011-08-18 | 2013-02-21 | Axella Solutions, Llc | Production of infectious rna viruses in yeast |
US9463236B2 (en) | 2011-08-29 | 2016-10-11 | Tokushima University | RSV mucosal vaccine |
AU2014214763B2 (en) | 2013-02-08 | 2020-02-27 | The Research Foundation For The State University Of New York | Attenuation of human respiratory syncytial virus by genome scale codon-pair deoptimization |
EP2970981B1 (en) * | 2013-03-14 | 2020-10-28 | Emory University | Recombinant rsv with silent mutations, vaccines, and methods related thereto |
US10369213B2 (en) | 2013-10-16 | 2019-08-06 | Merck Sharp & Dohme Corp. | Thermostable respiratory synctial virus (RSV) vaccine compositions |
WO2015057540A1 (en) | 2013-10-16 | 2015-04-23 | Merck Sharp & Dohme Corp. | Method of microwave vacuum drying spherical-shaped pellets of biological materials |
WO2017030997A1 (en) * | 2015-08-14 | 2017-02-23 | Research Institute At Nationwide Children's Hospital | Respiratory syncytial virus having altered ns1 protein function and related materials and methods |
BR112018008708A2 (pt) | 2015-10-29 | 2018-11-06 | Univ Emory | rsv quimérico, composições imunogênicas e métodos de uso |
WO2018057950A1 (en) | 2016-09-23 | 2018-03-29 | The Usa, As Represented By The Secretary, Dept. Of Health And Human Services | Vaccine candidates for human respiratory syncytial virus (rsv) having attenuated phenotypes |
TW202228779A (zh) | 2017-03-01 | 2022-08-01 | 英商梅迪繆思有限公司 | 抗rsv單株抗體配製物 |
KR20200096904A (ko) * | 2017-09-15 | 2020-08-14 | 오하이오 스테이트 이노베이션 파운데이션 | 호흡기 세포융합 바이러스(rsv) 감염의 예방을 위한 백신 및 백신의 제조 및 사용 방법 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997038138A1 (en) * | 1996-04-04 | 1997-10-16 | The Regents Of The University Of Michigan | Attenuated respiratory syncytial virus |
JP2002507408A (ja) | 1998-03-26 | 2002-03-12 | アメリカン・サイアナミド・カンパニー | 麻疹ウイルスもしくはヒト呼吸合胞体ウイルスサブグループbの弱毒化の原因である突然変異 |
CN100354425C (zh) | 1999-07-09 | 2007-12-12 | 美国政府健康及人类服务部 | 减毒的人-牛嵌合呼吸道合胞病毒疫苗的生产 |
EP1572108A4 (en) | 2002-09-27 | 2008-09-17 | Medimmune Vaccines Inc | FUNCTIONAL MUTATIONS OF RSV (RESPIRATORY SYNCYTIAL VIRUS) |
CA2520671C (en) * | 2003-03-28 | 2014-03-18 | Medimmune Vaccines, Inc. | Compositions and methods involving respiratory syncytial virus subgroup b strain 9320 |
US20100323428A1 (en) * | 2007-02-07 | 2010-12-23 | Dnavec Corporation | Attenuated minus-stranded rna virus |
EP2346990B1 (en) * | 2008-11-05 | 2016-01-06 | Merck Sharp & Dohme Corp. | Live, attentuated respiratory syncytial virus |
-
2009
- 2009-11-03 EP EP09748199.8A patent/EP2346990B1/en active Active
- 2009-11-03 RU RU2011122615/10A patent/RU2011122615A/ru not_active Application Discontinuation
- 2009-11-03 CN CN2009801537266A patent/CN102272295A/zh active Pending
- 2009-11-03 US US13/127,647 patent/US9011876B2/en active Active
- 2009-11-03 BR BRPI0921424A patent/BRPI0921424A2/pt not_active IP Right Cessation
- 2009-11-03 MX MX2011004719A patent/MX2011004719A/es unknown
- 2009-11-03 CA CA2742086A patent/CA2742086A1/en not_active Abandoned
- 2009-11-03 PE PE2011000971A patent/PE20110394A1/es not_active Application Discontinuation
- 2009-11-03 KR KR1020117010304A patent/KR20110063863A/ko not_active Application Discontinuation
- 2009-11-03 JP JP2011534864A patent/JP5016731B2/ja not_active Expired - Fee Related
- 2009-11-03 AU AU2009311287A patent/AU2009311287C1/en not_active Ceased
- 2009-11-03 WO PCT/US2009/063024 patent/WO2010053883A1/en active Application Filing
-
2011
- 2011-04-17 IL IL212437A patent/IL212437A0/en unknown
- 2011-04-19 TN TN2011000182A patent/TN2011000182A1/fr unknown
- 2011-05-04 CL CL2011000999A patent/CL2011000999A1/es unknown
- 2011-05-05 EC EC2011011033A patent/ECSP11011033A/es unknown
- 2011-05-05 ZA ZA2011/03259A patent/ZA201103259B/en unknown
- 2011-05-12 CO CO11058596A patent/CO6362047A2/es not_active Application Discontinuation
- 2011-06-03 MA MA33913A patent/MA32878B1/fr unknown
- 2011-08-05 JP JP2011171459A patent/JP5743794B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
TN2011000182A1 (en) | 2012-12-17 |
MX2011004719A (es) | 2011-05-31 |
ZA201103259B (en) | 2012-01-25 |
CO6362047A2 (es) | 2012-01-20 |
US20110212130A1 (en) | 2011-09-01 |
JP2012507302A (ja) | 2012-03-29 |
CL2011000999A1 (es) | 2012-07-20 |
JP5016731B2 (ja) | 2012-09-05 |
AU2009311287C1 (en) | 2015-02-19 |
WO2010053883A1 (en) | 2010-05-14 |
EP2346990A1 (en) | 2011-07-27 |
AU2009311287B2 (en) | 2013-02-07 |
ECSP11011033A (es) | 2011-12-30 |
EP2346990B1 (en) | 2016-01-06 |
CN102272295A (zh) | 2011-12-07 |
RU2011122615A (ru) | 2012-12-20 |
JP2011250798A (ja) | 2011-12-15 |
IL212437A0 (en) | 2011-06-30 |
JP5743794B2 (ja) | 2015-07-01 |
KR20110063863A (ko) | 2011-06-14 |
US9011876B2 (en) | 2015-04-21 |
BRPI0921424A2 (pt) | 2016-01-05 |
AU2009311287A1 (en) | 2010-05-14 |
MA32878B1 (fr) | 2011-12-01 |
CA2742086A1 (en) | 2010-05-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PE20110394A1 (es) | Virus sincitial respiratorio vivo atenuado | |
MX2011011960A (es) | Peptidos penetradores de celulas. | |
HRP20200871T1 (hr) | Izmjenjeni rsv f proteini i postupci njihove uporabe | |
CL2012000119A1 (es) | Polipeptido f de virus respiratorio sincicial recombinante, composicion inmunogenica que lo comprende, uso para la preparacion de un medicamento para la profilaxis contra dicho virus. | |
NZ570553A (en) | Immunogenic peptide sequences from influenza A and B and uses thereof for vaccines | |
PE20190420A1 (es) | Proteinas f de prefusion del virus respiratorio sincicial (vrs) solubles y estabilizadas | |
UA98620C2 (uk) | Атенуйований вірус класичної лихоманки свиней, що містить модифікований глікопротеїн е2 | |
PE20100253A1 (es) | Mutantes de fgf21 | |
NZ627888A (en) | Materials and methods for respiratory disease control in canines | |
AR086078A1 (es) | Proteinas de fusion y vacunas de combinacion | |
UA94717C2 (ru) | Модифицированный вирус гриппа, предназначенный для мониторинга и повышения эффективности вакцины | |
PE20090483A1 (es) | Vectores para la expresion multiple de genes | |
RU2009119597A (ru) | Новые белки н5, кодирующие их молекулы нуклеиновых кислот и векторы, и их применение в медицине | |
JP2010508030A5 (es) | ||
HK1129128A1 (en) | Recombinant human interferon-like proteins | |
BRPI0411363A (pt) | seqüências de ácidos nucléicos codificando e composições compreendendo peptìdeo sinal ige e/ou il-15 e processos para uso das mesmas | |
PE20110106A1 (es) | Peptidos mediadores del eflujo del colesterol mejorados | |
AR053372A1 (es) | Proteinas inmunologicas de lawsonia intracellularis | |
WO2009024327A3 (en) | New proteins for use in human and animal staphylococcus infections | |
ATE493497T1 (de) | Verfahren zur herstellung von oligopeptiden | |
WO2010057242A3 (de) | Vakzin | |
ATE469170T1 (de) | Zusammensetzungen und verfahren mit dem respiratory syncytial virus untergruppe b stamm 9320 | |
TW201008576A (en) | New fusion proteins and their use for the preparation of vaccines against hepatitis C | |
DK1778271T3 (da) | Peptid til behandling af herpesvirusinfektioner | |
ATE552271T1 (de) | Antitumorarzneimittel, medikament, zusammensetzung und anwendung davon |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD | Application declared void or lapsed |